4.5 Review

Respiratory problems in neurologic movement disorders

期刊

PARKINSONISM & RELATED DISORDERS
卷 16, 期 10, 页码 628-638

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.parkreldis.2010.07.004

关键词

Movement disorders; Respiratory; Parkinson; Myoclonus

资金

  1. Allergan, Inc
  2. Chelsea Therapeutics
  3. Helis Foundation
  4. Huntington's Disease Society of America
  5. Huntington Study Group
  6. Impax Pharmaceuticals
  7. Ipsen Limited
  8. Lundbeck Inc
  9. Medtronic
  10. Merz Pharmaceuticals
  11. National Institutes of Health
  12. National Parkinson Foundation
  13. Neurogen
  14. Novartis
  15. Ortho-McNeil
  16. St. Jude Medical
  17. Teva
  18. University of Rochester
  19. Parkinson Study Group

向作者/读者索取更多资源

Background: Movement disorders are a group of neurological motor disturbances manifested by either paucity or slowness of movement, such as seen in Parkinson's disease, or by abnormal involuntary movements, called hyperkinesias, which include tremor, dystonia, chorea, tics, myoclonus, and stereotypy. The aim of this review is to draw attention to the respiratory problems that are sometimes associated with these various movement disorders. Methods: References for this review were identified by searches of PubMed through June 2010, a text word search strategy. There were no language restrictions. Books on movement disorders, personal experience and judgment were also used in preparation of this review. Results: Data from 245 articles were critically reviewed, compared and integrated. Conclusion: Although movement disorders are primarily considered motor disorders, the purpose of this review is to draw attention to their involvement of the respiratory system. It is critical that clinicians recognize the phenomenology and take appropriate action to prevent and treat the various respiratory problems associated with the various neurological disorders. Timely institution of therapeutic interventions is needed to favorably impact on the quality of life and survival of these patients. (C) 2010 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
Article Clinical Neurology

The semicircular canal function is preserved with little impact on falls in patients with mild Parkinson's disease

Jun-Pyo Hong, Hanim Kwon, Euyhyun Park, Sun-Uk Lee, Chan-Nyoung Lee, Byung-Jo Kim, Ji-Soo Kim, Kun-Woo Park

Summary: In patients with mild-to-moderate PD, vestibular function assessed by video head-impulse tests appears relatively preserved and has minimal impact on the risk of falls. Risk of postural instability is associated with the severity of clinical symptoms in PD.

PARKINSONISM & RELATED DISORDERS (2024)

Article Clinical Neurology

Estimating the sequence of biomarker changes in Parkinson's disease

Yaqin Xiang, XiuRong Huang, Qian Xu, Zhenhua Liu, Yase Chen, Qiying Sun, Junling Wang, Hong Jiang, Lu Shen, Xinxiang Yan, Beisha Tang, Jifeng Guo

Summary: Using the novel data-driven method DEBM, this study determined the sequence of several common biomarker changes in Parkinson's disease (PD). The left putamen was found to be the earliest biomarker to become abnormal, followed by the right putamen, CSF alpha-synuclein, right caudate, left caudate, and serum NfL. The estimated disease stages showed significant differences between PD and healthy controls, and achieved a high accuracy for distinguishing PD from HC.

PARKINSONISM & RELATED DISORDERS (2024)

Article Clinical Neurology

Incidence and risk factors of institutionalisation in Parkinson's disease and atypical parkinsonism

Yan Li, David J. McLernon, Carl E. Counsell, Angus D. Macleod

Summary: This study aimed to investigate the incidence and risk factors for institutionalisation in Parkinson's disease (PD) and atypical parkinsonism (AP). The study found that institutionalisation was more frequent in AP compared to PD and controls. Age, poorer cognition, and more-severe parkinsonian impairment were independent predictors of institutionalisation.

PARKINSONISM & RELATED DISORDERS (2024)